Search Results

Pricing can change depending on the number of participants joining the team.

Deadline 1st round priority: June 24th / 2nd round: July 22th Do you have an artistic side? Let’s dive into the Classified GPCR News from June 3rd to June 9th, 2024. GPCRs and Emotional Pain: Exploring Non-Narcotic Pathways to Relief GPCR Events, Meetings, and Webinars June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein Mediated Signaling Networks June 25 - 29, 2024 | FENS

Let’s dive into the Classified GPCR News from June 24th to 30th, 2024 Adhesion GPCRs Novel Isoforms of

Let’s dive into the Classified GPCR News from June 17th to 23rd, 2024. mechanotransduction at endothelial junctions GPCRs in Neuroscience Male-specific behavioral and transcriptomic changes Tectonic plates more than $130m in new funding and goes public GPCR Events, Meetings, and Webinars NEW June 27, 2024 | FREE GPCR Forum ECI Zoominar June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein Mediated Signaling Networks June 25 - 29, 2024 | FENS Forum 2024 NEW September 18, 2024 | FREE Webinar - The

Authors Ze Wu , Qiongqiong Jia , Boqun Liu , Lanlan Fang , Peter C K Leung , Jung-Chien Cheng Tags Invasion

and Immunology Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia Published date June Authors Guangrong Qin, Jin Dai, Sylvia Chien, Timothy J Martins, Brenda Loera, Quy H Nguyen, Melanie

Juan José Fung About Dr. Juan José Fung Dr. Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused Fung received his Ph.D. from the Stanford University School of Medicine under the mentorship of Dr. Fung continued his Postdoctoral training in Dr. Juan José Fung on the web LinkedIn GPCR Therapeutics Dr.